AMGN Today - Aug 13: Steady Day for Amgen

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

AMGN Today - Aug 13: Steady Day for Amgen

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly long-time investor, breaking down the day’s action. Today we’re talking about Amgen, and guess what? It had a pretty chill day, barely moving up by 0.38%.

So, what went down? Amgen’s stock price closed at around 417.75. Yeah, not a wild ride at all—just kind of floated along. Volume was steady, matching its average, which means folks weren’t rushing to buy or sell like crazy. It’s like everyone was just hanging out, not too worried.

Now, why did it stay so steady? Well, there’s some chatter about Amgen’s recent performance. They posted strong Q2 results and even raised their guidance for 2026. That’s usually a good sign, right? But here’s the kicker: some analysts are saying it might be fully valued now. So, while the numbers look solid, there’s a bit of caution in the air. People are trying to figure out if it’s worth chasing after or if it’s already priced in. Also, Daiwa Securities just bumped their price target to $430 from $390, which is a bit of a boost, but again, it’s all about how investors feel about that valuation.

Oh, and just a little nugget for you—Tema ETFs just increased their stake in Amgen. So, some folks are still feeling good about it, even if the stock’s taking a breather today.

That’s the scoop! Amgen’s playing it cool, and while there’s some optimism with the earnings and guidance, there’s also that nagging feeling about whether it’s peaked. Just remember, this is all for fun and info—no financial advice here. Catch you later!

まだレビューはありません